Physician profile
David Onofrey
NPI 1083685598
$747.58
in general payments reported to CMS, 2019-2025
18 companies · $44.22 in 2025
The $44.22 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $249 · 2020: $48.03 · 2021: $180 · 2022: $151 · 2023: $32.22 · 2024: $43.46 · 2025: $44.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $119.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innocoll Pharmaceuticals Limited | $147.77 | 2021-2022 | |
| Pacira Pharmaceuticals Incorporated | $124.99 | 2021 | |
| Smith+Nephew, INC. | $90.65 | 2019-2024 | Collagenase Santyl, Pico, Renasys Go V2 Home |
| Nuvasive, INC. | $62.32 | 2019 | |
| Olympus America INC. | $46.98 | 2019 | |
| Baxter Healthcare | $46.88 | 2019-2025 | Perclot |
| Intuitive Surgical, INC. | $32.42 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $27.66 | 2025 | |
| Medtronic, INC. | $24.75 | 2021 | |
| Tactile Systems Technology INC | $19.44 | 2020 | |
| Mallinckrodt Enterprises LLC | $18.45 | 2019 | |
| Abbott Laboratories | $17.81 | 2021 | |
| Convatec INC. | $16.04 | 2023 | |
| Mallinckrodt Hospital Products INC. | $15.94 | 2020 | |
| Csl Behring | $14.53 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $14.31 | 2019 | |
| Focal Therapeutics, INC. | $13.99 | 2019 | |
| Reprise Biomedical, INC. | $12.65 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Onofrey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.